Why is Microsoft stock sliding today?

Microsoft beat Q3 FY2026 expectations with revenue of $82.89B versus $81.39B expected and EPS of $4.27 versus $4.06, but the stock fell 5.3% after management guided full-year capex to $190B, well above the $154.6B consensus. The capex outlook implies sharper margin pressure, with gross margin at 67.6% and fiscal Q4 operating margin expected around 44% versus 46.3% previously. Scotiabank cut its price target to $550 from $600, and Guardcap reduced its MSFT stake by 248,665 shares.

Analysis

The market is no longer paying for AI narrative; it is discounting the financing bill. When capex ramps faster than revenue reacceleration, the first-order hit is margin compression, but the second-order effect is more important: management loses flexibility to defend software growth with buybacks, M&A, or pricing concessions if enterprise demand slows. That makes MSFT vulnerable to any further multiple compression from investors who start treating it less like a high-quality software compounder and more like a utility with heavy reinvestment needs.

This setup also shifts the competitive balance inside the AI stack. The biggest beneficiaries are likely the picks-and-shovels suppliers with pricing power on memory, networking, and power/cooling, while lower-tier AI infrastructure vendors could see near-term order pull-forward followed by digestion if hyperscalers re-forecast spend. Over the next 1-2 quarters, the key risk is not that AI demand disappears, but that return-on-capital scrutiny rises faster than utilization, forcing a slower spending cadence across the sector and pressuring names whose valuation already assumes sustained hypergrowth.

The catalyst path is asymmetric: near term, every incremental capex disclosure or margin comment can trigger another de-rating, while a reversal likely requires evidence that incremental AI revenue is scaling enough to justify the buildout. The consensus is probably underestimating how quickly investors will punish “good results, bad spend,” especially when macro is already tightening financial conditions and making duration-sensitive growth names less forgiving. That said, the selloff can become overdone if the stock prices in a multi-year impairment from a single-year capex spike; if management signals spend normalization into next fiscal year, the stock could snap back sharply.

This is a tradable relative-value event more than a pure directional short. The cleanest expression is to stay short MSFT versus the broader software complex if margin fears spread, but use options to avoid fighting a quality balance sheet in case the market decides the capex is temporary. The best risk/reward likely sits in a time-limited window around the next disclosure cycle, when investors will either see evidence of monetization or begin cutting estimates again.

Key Decisions for Investors

• Short MSFT on strength over the next 1-3 weeks, targeting a move back toward the prior consolidation band; use a tight stop if management explicitly signals capex normalization or improved AI payback metrics.
• Buy MSFT put spreads 1-3 months out to express further multiple compression while limiting premium burn; best risk/reward if implied volatility stays below realized post-earnings volatility.
• Pair trade: long infrastructure enablers with pricing power vs. short lower-quality AI beneficiaries; the cleaner version is long a power/cooling or memory supplier basket versus short AI software names with no near-term monetization proof.
• Reduce exposure to software high-multiples that depend on margin expansion over the next 2 quarters; if MSFT is being repriced as capex-heavy, the market may rotate out of adjacent peers with similar AI spend profiles.
• Set a tactical alert for the next capex or margin update: if management does not raise the expected fiscal 2027 ROI narrative, add to shorts on any relief rally; if they do, cover quickly because the stock can re-rate fast on any credible normalization path.